Analyst consensus rating
Amphastar Pharmaceuticals, Inc. Analyst Rating: Hold
AMPH is rated Hold by 6 analysts with a $22.00 target. As of 2026-08-16.
Direct answer
Amphastar Pharmaceuticals, Inc.'s consensus rating is Hold.
6 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $22.00.
Forecast evidence checked August 16, 2026.
Get free Amphastar Pharmaceuticals, Inc. email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $20.91
- Average price target
- $22.00
- High price target
- $30.00
- Low price target
- $20.00
- Low target gap
- -4.4%
- Target upside
- +5.2%
- High target gap
- +43.5%
- Target range width
- 47.8%
- Consensus rating
- Hold
- Analysts
- 6
- Evidence date
- August 16, 2026
- Valid through
- August 23, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for Amphastar Pharmaceuticals, Inc.?
Amphastar Pharmaceuticals, Inc. has a verified Hold consensus. The same dataset has an average price target of $22.00.
How far are Amphastar Pharmaceuticals, Inc.'s low and high targets from the recorded price?
The low target implies -4.4%, while the high target implies +43.5%.
How many analysts are included in Amphastar Pharmaceuticals, Inc.'s consensus?
The verified consensus includes 6 analysts.
How is Amphastar Pharmaceuticals, Inc.'s target upside or downside calculated?
The average target of $22.00 is divided by the recorded price of $20.91, then one is subtracted to produce +5.2%. This does not guarantee a future return.
When was Amphastar Pharmaceuticals, Inc.'s analyst forecast verified?
The data was verified on 2026-08-16. The dataset is valid through 2026-08-23.